Sex differences in escape-avoidance response in mice after acute administration of raclopride, clozapine, and SCH 23390.
Sex differences in the effects of haloperidol in the escape-avoidance response in mice have previously been found in various studies carried out in our laboratory. Males were more affected than females by the disruptive effects of this neuroleptic. The work described herein extended the study of these sex differences to raclopride, clozapine, and SCH 23390, using several doses of each drug in acute administration. The results showed dose-dependent sex differences in the deteriorating effects of these dopamine antagonists in the escape-avoidance response. Male mice were more affected by the inhibitory effects of these drugs, showing fewer escape responses and more nonresponses than females. Sex differences were found with all three of the dopamine antagonists studied, indicating, therefore, that these differences do not depend on a unique type of dopaminergic receptor. The results obtained in motor activity, measured by the number of crossings during the adaptation period and the intertrial intervals, suggest that the motor effects are not the origin of these differences. It is concluded that, besides haloperidol, other dopamine antagonists also show sex differences in their behavioral effects in escape-avoidance response in mice, with males being more affected than females by the inhibitory action of these drugs.
Monleón
S
S
Area de Psicobiología, Facultad de Psicología, Universitat de València, Spain.
Vinader-Caerols
C
C
Parra
A
A
D000818:Animals; D001362:Avoidance Learning / Q000502:physiology*; D001552:Benzazepines / Q000494:pharmacology*; D003024:Clozapine / Q000494:pharmacology*; D018492:Dopamine Antagonists / Q000494:pharmacology*; D065127:Dopamine D2 Receptor Antagonists; D004305:Dose-Response Relationship, Drug; D004924:Escape Reaction / Q000502:physiology*; D005260:Female; D008297:Male; D051379:Mice; D020891:Raclopride; D017447:Receptors, Dopamine D1 / Q000037:antagonists & inhibitors; D012457:Salicylamides / Q000494:pharmacology*; D012727:Sex Characteristics
D001552:Benzazepines; D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists; D017447:Receptors, Dopamine D1; D012457:Salicylamides; D020891:Raclopride; D003024:Clozapine